PDCD1 and neoplasm: PD-1 deficiency or blockade leads to compensatory upregulation of co-inhibitory receptors—such as CD30, CTLA4, and GITR—through enhanced STAT5 signaling, generating a hyperfunctional Treg phenotype that amplifies immunosuppression and fosters an immune-cold tumor microenvironment (37).